As our country continues to make headway in the COVID-19 pandemic, it is encouraging to realize
61.3% of the U.S. adult population has currently received at least one dose of a COVID-19 vaccine, moving us closer to the President’s goal of 70% by July 4, 2021.
Key highlights for this update:
- Pfizer/BioNTech COVID-19 vaccine is now approved for adolescents beginning at age 12 years.
- Updated CDC guidance for fully vaccinated and unvaccinated individuals.
FDA/ACIP APPROVAL FOR COVID-19 VACCINE FOR 12 YEARS OF AGE AND OLDER
On May 10, 2021, the FDA approved the Pfizer/BioNTech COVID-19 vaccine down to ages 12 years and older under emergency use authorization (EUA). On May 12, 2021, the Advisory Committee on Immunization Practices (ACIP) met and deliberated on the expanded use of the Pfizer/BioNTech COVID-19 vaccine giving their support and recommendations. The CDC Director adopted those recommendations and the Pfizer/BioNTech COVID-19 vaccine for this age group is now covered under health insurance.
Have additional questions regarding COVID-19 vaccination in pediatrics?
We recommend these resources:
VACCINE INFORMATION FOR SPECIFIC GROUPS
Additional guidance on specific groups, such as long-term care residents, essential workers, and those who are pregnant or lactating, becomes available a
s vaccination efforts progress.
GUIDANCE FOR FULLY VACCINATED INDIVIDUALS
GUIDANCE FOR UNVACCINATED INDIVIDUALS
For information on protecting yourself and others while you are unvaccinated, please visit the CDC Guidance for Unvaccinated Individuals.